Cargando…
Hypomethylation of thymosin β4 promoter is associated with glucocorticoid therapy in patients with acute-on-chronic hepatitis B-induced liver failure
BACKGROUND: We aimed to determine whether the methylation status of thymosin β4 (Tβ4) promoter reflects the severity of acute-on-chronic hepatitis B liver failure (ACHBLF) and whether glucocorticoids affect this status. METHODS: Fifty-six patients with ACHBLF, 45 with chronic hepatitis B (CHB) and 3...
Autores principales: | Wang, He, Qian, Yu, Wang, Jing-Wen, Fang, Yu, Fan, Yu-Chen, Liu, Hui-Hui, Wang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808517/ https://www.ncbi.nlm.nih.gov/pubmed/35150577 http://dx.doi.org/10.1093/inthealth/ihac003 |
Ejemplares similares
-
Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure
por: Zhao, Qian, et al.
Publicado: (2019) -
Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Hui-Hui, et al.
Publicado: (2020) -
The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease
por: Liang, Jing, et al.
Publicado: (2016) -
Hepatic Stellate Cells Express Thymosin Beta 4 in Chronically Damaged Liver
por: Kim, Jieun, et al.
Publicado: (2015) -
Early prediction model for prognosis of patients with hepatitis-B-virus-related acute-on-chronic liver failure received glucocorticoid therapy
por: Gao, Shuai, et al.
Publicado: (2022)